JP Morgan Initiates Coverage On Arco Platform with Neutral Rating, Announces Price Target of $22
JP Morgan analyst Marcelo Santos initiates coverage on Arco Platform (NASDAQ:ARCE) with a Neutral rating and announces Price Target of $22.
60 Biggest Movers From Yesterday
Gainers
Bone Biologics Corporation (NASDAQ: BBLG) shares surged 57.1% to close at $5.39 on Monday.
Earnings Scheduled For November 29, 2021
Companies Reporting Before The Bell
• Quhuo (NASDAQ:QH) is expected to report quarterly earnings at $0.11 per share on revenue of $180.09 million.
54 Biggest Movers From Yesterday
Gainers
Longeveron Inc. (NASDAQ: LGVN) shares climbed 135.3% to close at $6.87 on Thursday. Longeveron said the FDA granted rare pediatric disease designation for the company’s Lomecel-B for the treatment of hypoplastic left heart syndrome.
44 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Longeveron Inc. (NASDAQ: LGVN) jumped 157% to $7.51. Longeveron said the FDA granted rare pediatric disease designation for the company’s Lomecel-B for the treatment of hypoplastic left heart syndrome.
Arco Receives Antitrust Approval and Completes the Acquisition of COC and Dom Bosco Learning Systems
Arco Platform Limited, or Arco (NASDAQ:ARCE),today announced that it received, on September 30, 2021, final antitrust approval from Brazil's Administrative Council for Economic Defense – CADE, with no
58 Biggest Movers From Friday
Gainers
Regencell Bioscience Holdings Limited (NASDAQ: RGC) shares climbed 204.1% to close at $19.16 on Friday. Regencell Bioscience reported partial exercise of underwriter’s over-allotment option.
38 Stocks Moving In Friday’s Mid-Day Session
Gainers
Regencell Bioscience Holdings Limited (NASDAQ: RGC) shares jumped 175% to $17.33. Regencell Bioscience reported partial exercise of underwriter’s over-allotment option.